Table 2 Detailed information on datasets included in this study

From: Integrating bulk, single-cell, and spatial transcriptomics to identify and functionally validate novel targets to enhance immunotherapy in NSCLC

Dataset

Case/Sample

Stage

Cancer type

Data type

Treatment

TCGA-LUAD

514/569

Early and advanced stage

LUAD

RNA-seq

Unknown

ICGC-LUAD

425/425

Early and advanced stage

LUAD

RNA-seq

Unknown

GSE31210

226/226

Early stage

LUAD

RNA-seq

Unknown

GSE72094

442/442

Early and advanced stage

LUAD

RNA-seq

Unknown

GSE50081

181/181

Early stage

NSCLC

RNA-seq

Unknown

GSE37745

196/196

Unknow

NSCLC

RNA-seq

Unknown

GSE78220

28/28

Advanced stage

Melanoma

RNA-seq

Chemotherapy with Anti-PD-1 Therapy

GSE67501

11/11

Unknow

HRCC

RNA-seq

Chemotherapy with Anti-PD-1 Therapy

GSE135222

27/27

Advanced stage

NSCLC

RNA-seq

Chemotherapy with Anti-PD-L1/PD-1 Therapy

GSE165252

77/77

Unknow

ESCA

RNA-seq

Chemotherapy with Anti-PD-L1 Therapy

IMvigor210

310/310

Unknow

BUC

RNA-seq

Chemotherapy with Anti-PD-L1 Therapy

GSE126044

16/16

Unknow

NSCLC

RNA-seq

Chemotherapy with Anti-PD-1 Therapy

GSE190265

34/34

Advanced stage

NSCLC

RNA-seq

Chemotherapy with Anti-PD-L1/PD-1 Therapy

Philip Bischoff’s study

12/24

Early stage

LUAD

scRNA-seq

Unknown

GSE123902

14/17

Early and advanced stage

LUAD

scRNA-seq

Unknown

GSE131907

44/58

Early and advanced stage (tLung, tL/B, mLN, and mBrain)

LUAD

scRNA-seq

Unknown

GSE207422

8/8

Early stage

NSCLC

scRNA-seq

Chemotherapy with Anti-PD-1 Therapy

GSE189357

6/6

Early stage (AIS, MIA, and IAC)

LUAD

scRNA-seq

Unknown

GSE200563

35/109

Early and advanced stage (L, mLN, and LB)

NSCLC

DSP

Unknown

GSE189487

6/6

Early stage (AIS, MIA, and IAC)

LUAD

Visium

Unknown

  1. LUAD lung adenocarcinoma, NSCLC non-small cell lung carcinoma, HRCC human renal cell carcinoma, ESCA esophageal adenocarcinoma, BUC bladder urothelial carcinoma, tLung lung cancer in situ, tL/B lung cancer with metastasis, mLN metastatic lymph node, mBrain brain metastases, L primary lung carcinoma, LB brain metastasis, AIS lung adenocarcinoma in situ, MIA minimally invasive adenocarcinoma, IAC invasive adenocarcinoma, DSP digital spatial profiler, RNA-seq RNA sequencing, scRNA-seq single-cell RNA sequencing.